Your browser doesn't support javascript.
Practical recommendations for the management of diabetes in patients with COVID-19.
Bornstein, Stefan R; Rubino, Francesco; Khunti, Kamlesh; Mingrone, Geltrude; Hopkins, David; Birkenfeld, Andreas L; Boehm, Bernhard; Amiel, Stephanie; Holt, Richard Ig; Skyler, Jay S; DeVries, J Hans; Renard, Eric; Eckel, Robert H; Zimmet, Paul; Alberti, Kurt George; Vidal, Josep; Geloneze, Bruno; Chan, Juliana C; Ji, Linong; Ludwig, Barbara.
  • Bornstein SR; Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany; Paul Langerhans Institute Dresden of the Helmholtz Center Munich, University Hospital Carl Gustav Carus, Dresden, Germany; Department of Diabetes, School of Life Course Science and Medicine, King's College London, L
  • Rubino F; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK; Bariatric and Metabolic Surgery, King's College Hospital, London, UK.
  • Khunti K; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Mingrone G; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK; Fondazione Policlinico Universitario Agostino Gemelli Istituto Di Ricovero e Cura a Carattere Scientifico, Rome, Italy; Department of Internal Medicine, Università Cattolica del Sacro Cuore, Rome,
  • Hopkins D; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK; Institute of Diabetes Endocrinology and Obesity, King's Health Partners, London, UK.
  • Birkenfeld AL; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany; Department of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Tübingen, Germany; Institute for Diabetes
  • Boehm B; Department of Endocrinology, Tan Tock Seng Hospital, Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University Singapore, Singapore.
  • Amiel S; Department of Diabetes, School of Life Course Science and Medicine, King's College London, London, UK.
  • Holt RI; Human Development and Health, Faculty of Medicine, University of Southampton, UK.
  • Skyler JS; Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
  • DeVries JH; Department of Endocrinology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Profil Institute for Metabolic Research, Neuss, Germany.
  • Renard E; Montpellier University Hospital and Institute of Functional Genomics, Centre national de la recherche scientifique, INSERM, University of Montpellier, Montpellier, France.
  • Eckel RH; Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Zimmet P; Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Alberti KG; Division of Diabetes, Endocrinology and Metabolism, Imperial College, London, UK.
  • Vidal J; Centro de Investigación Biomédica en Red en Diabetes y Enfermedades Metabólicas Asociadas, Barcelona, Spain.
  • Geloneze B; Obesity and Comorbities Research Center, Laboratory of Investigation in Metabolism and Diabetes/Gastrocentro, Universidade de Campinas, Campinas, São Paulo, Brazil.
  • Chan JC; Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity and Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
  • Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing, China.
  • Ludwig B; Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany; Paul Langerhans Institute Dresden of the Helmholtz Center Munich, University Hospital Carl Gustav Carus, Dresden, Germany; Department of Endocrinology and Diabetology, University Hospital Zurich, Zurich, Switzerland
Lancet Diabetes Endocrinol ; 8(6): 546-550, 2020 06.
Article in English | MEDLINE | ID: covidwho-108776
ABSTRACT
Diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus 2. Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20-50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, we have formed an international panel of experts in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic. We aim to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Pandemics / Betacoronavirus / Hypoglycemic Agents Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Diabetes Endocrinol Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 / Pandemics / Betacoronavirus / Hypoglycemic Agents Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Diabetes Endocrinol Year: 2020 Document Type: Article